Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases.
about
Update in genetic susceptibility in melanomaThe roles of chromatin-remodelers and epigenetic modifiers in kidney cancerLoss of BAP1 Expression Occurs Frequently in Intrahepatic CholangiocarcinomaLoss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytologyComprehensive review of BAP1 tumor predisposition syndrome with report of two new casesBAP1 hereditary cancer predisposition syndrome: a case report and review of literatureAnalysis of BAP1 Germline Gene Mutation in Young Uveal Melanoma PatientsBAP1, a tumor suppressor gene driving malignant mesothelioma.Melanoma genetics.Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma.Genetics of familial melanoma: 20 years after CDKN2A.Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival.Nephron-sparing surgery for multifocal and hereditary renal tumors.Somatic alteration and depleted nuclear expression of BAP1 in human esophageal squamous cell carcinoma.Hereditary melanoma: Update on syndromes and management: Emerging melanoma cancer complexes and genetic counselingGermline BAP1 mutations misreported as somatic based on tumor-only testingThe Importance of Multidisciplinary Approach in Early Detection of BAP1 Tumor Predisposition Syndrome: Clinical Management and Risk Assessment.Germline BAP1 alterations in familial uveal melanoma.[Hereditary renal tumors: More common than expected?].Somatic BRCA1-associated protein 1 (BAP1) loss is an early and rare event in esophageal adenocarcinoma.A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma.Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area.Genetic prognostication in uveal melanoma.Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature.Patterns of BAP1 protein expression provide insights into prognostic significance and the biology of uveal melanoma.Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.Genomic spectra of biliary tract cancer.Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome.Detecting germline BAP1 mutations in patients with peritoneal mesothelioma: benefits to patient and family members.Molecular pathology of cutaneous melanomaStaging Uveal Melanoma with Whole-Body Positron-Emission Tomography/Computed Tomography and Abdominal Ultrasound: Low Incidence of Metastatic Disease, High Incidence of Second Primary Cancers
P2860
Q26778756-67F28906-628A-451D-91CA-23036ABDF3CFQ28083152-99B3123A-C4A7-4623-A094-F646D2BE99A8Q28384496-122C9684-2A34-494A-9C73-7D49C2038018Q28387556-7A237360-81A0-40B0-BD78-E6EB10A91BACQ28397229-CDF6C778-FD5C-4F12-86B8-E9F46827918AQ28397624-C1C842F4-4D44-4951-B35C-D470F305F853Q30382522-550CA680-1CF6-41AC-8894-9A0CA682935BQ33890512-CF99554C-8E98-4CF1-A50A-1154538C9D23Q34044830-16CDE9A2-37A4-4E98-ABA0-567F7E59ECC9Q34194566-0AC94565-0DC5-4DB8-86A3-ED64A82CAAC5Q34449957-16044D6B-4FD2-4FD9-A5A9-CA72F727EA6EQ34917972-877C59C3-2877-4FAF-8BB8-832FE4D95121Q35638401-AE3268B9-3247-402A-A87E-54436DC57664Q36092850-B2F7A490-ECF5-4A08-B468-A7D35E7FC520Q36599690-ABADF118-51A9-4557-B185-D89662DFCCF4Q37171825-7FED55DE-6DCC-41DA-A5CE-97EF7936B661Q38214084-446BE2BD-7AF6-4680-B7FD-AC0114A78FA1Q38805682-4A69B6D2-768E-4F3A-B109-455F760FDE9CQ40852568-12BD6AF1-9EED-48F4-A590-C237928E9E9DQ41162225-8118F527-301D-4487-BAA5-74149BD8539CQ42465699-4B250DD0-7F84-48ED-95CE-BFD6DF6B2D0CQ45361587-AB16621C-6ECC-421E-AB28-100C2D5E46A1Q47858202-A470B520-B618-4576-B23C-6A66957FA6A3Q47972869-2352DFF4-2F40-42D7-AEAC-7612D4A97688Q49698247-A3837D24-8CE2-42C7-9735-1CD7117D5358Q50222046-26CB91FF-60A1-4BBF-A2E4-7B63AA3AEBE1Q53390123-44D5CBCC-3C55-4024-AF09-425C2CB603BFQ53533612-8BD8B1DC-2593-4F50-8A8A-D4654141802EQ55665416-E0BA41EF-8C19-41E6-BFD4-F47073DB8635Q56428911-8264EDEB-D31D-4A46-9102-3F3251560F10Q57646732-AF058005-5CB9-4749-B165-DEC9D3604BE2
P2860
Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Expanding the clinical phenoty ...... me, reporting three new cases.
@ast
Expanding the clinical phenoty ...... me, reporting three new cases.
@en
type
label
Expanding the clinical phenoty ...... me, reporting three new cases.
@ast
Expanding the clinical phenoty ...... me, reporting three new cases.
@en
prefLabel
Expanding the clinical phenoty ...... me, reporting three new cases.
@ast
Expanding the clinical phenoty ...... me, reporting three new cases.
@en
P2093
P2860
P50
P356
P1476
Expanding the clinical phenoty ...... ome, reporting three new cases
@en
P2093
Barbara McGillivray
Frederick H Davidorf
James B Massengill
Louise Strong
Mary-Jill Asrat
Robert Pilarski
Thereasa Rich
P2860
P304
P356
10.1002/GCC.22129
P577
2013-11-15T00:00:00Z